— Know what they know.
Not Investment Advice

CTEV NYSE

Claritev Corporation
1W: +1.1% 1M: +0.7% 3M: -3.3% YTD: -33.2% 1Y: -67.5% 3Y: -63.0% 5Y: -88.9%
$22.65
+1.11 (+5.15%)
 
Weekly Expected Move ±8.6%
$19 $21 $24 $26 $28
NYSE · Healthcare · Medical - Healthcare Information Services · Tech Score Sell · Power 40 · $383.9M mcap · 7M float · 2.16% daily turnover · Short 45% of daily vol
Credit Risk of going bust: higher than 96% of companies Debt: 92.3% of company value Bonds: none of note held by US funds details ▾
Of US companies ranked in the riskiest tenth, about 1 in 20 filed for bankruptcy within a year (2020-2025).
If the stock fell to about $19.38 (down 14%), Claritev Corporation would be worth roughly what it owes.
Total debt $4.62B against a stock market value of $383.9M.
Distance to default 0.10 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $2.32B (short-term plus half of long-term), stock volatility 127.1%; Altman Z'' -1.71. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.

Edge Score

Quantitative competitive moat analysis scoring five pillars of durable advantage — cost leadership, brand intangibles, switching costs, network effects, and efficient scale — using industry percentile rankings on a 0–100 scale.

WEAK EDGE
43.6 / 100
NoneWeakNarrowWide
Primary source: Cost Advantage  ·  ROIC: 0.9%
Cost Advantage ★
63
Intangibles
28
Switching Cost
58
Network Effect
23
Scale
40
The Edge Score quantifies a company's competitive moat using five pillars: Cost Advantage (20%, operating margin and SG&A efficiency vs industry peers), Intangible Assets (25%, gross margin premium, R&D intensity, brand pricing power), Switching Costs (25%, revenue stability, earnings consistency, customer retention proxied by operating leverage), Network Effects (15%, revenue growth with expanding margins, market share dominance), and Efficient Scale (15%, market concentration, ROIC sustainability). Each pillar is scored 0–100 using industry percentile rankings, then weighted into a composite. Wide ≥ 70, Narrow ≥ 55, Weak ≥ 40, None < 40. CTEV shows a Weak competitive edge (43.6/100) — limited structural advantages that may face competitive pressure. The primary source of advantage is Cost Advantage. ROIC of 0.9% suggests modest returns relative to capital deployed.

Analyst Insights

Wall Street analyst consensus based on price targets and buy/sell/hold recommendations from institutional research coverage over the trailing 12 months.

Analyst Price Targets
$40
Low
$52
Avg Target
$73
High
Based on 3 analysts since Aug 7, 2026 earnings
Analyst Recommendations
Strong Buy: 0Buy: 5Hold: 1Sell: 0Strong Sell: 0
Rating Summary
ConsensusBuy
Avg Target$52.00
Analysts3
Price Target Change History
DateFirmAnalystOldNewChangeUpside @ CallStock@Call
2026-08-20 Barclays Glen Santangelo $28 $40 +12 +15.7% $34.57
2026-08-12 Piper Sandler Jessica Tassan $61 $73 +12 +106.4% $35.36
2026-08-10 Canaccord Genuity — $37 $43 +6 +31.9% $32.59
2026-07-21 Canaccord Genuity — Initiated $37 — +22.8% $30.12
2026-06-03 Piper Sandler — Initiated $61 — +144.0% $25.00
2026-04-24 Barclays — Initiated $28 — +37.9% $20.30
2026-02-24 Wells Fargo Stan Berenshteyn $33 $30 -3 +29.1% $23.23
2026-02-24 Guggenheim — Initiated $38 — +63.6% $23.23
2026-01-08 Wells Fargo Stan Berenshteyn Initiated $33 — +5.7% $31.21

Financial Rating

Composite financial health rating (A+ to F) based on discounted cash flow valuation, return on equity, return on assets, debt-to-equity leverage, and relative P/E and P/B multiples.

C+
Oct 27, 2026
DCF
3
ROE
5
ROA
1
D/E
1
P/E
1
P/B
1
The Financial Rating evaluates six fundamental factors — discounted cash flow (DCF) valuation, return on equity (ROE), return on assets (ROA), debt-to-equity leverage (D/E), and relative price-to-earnings (P/E) and price-to-book (P/B) multiples — each scored 1–5. CTEV receives an overall rating of C+. Strongest factors: ROE (5/5). Areas of concern: ROA (1/5), D/E (1/5), P/E (1/5), P/B (1/5).
Rating Change History
DateFromTo
2026-02-24 C C+

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

★ ★ ★ ★ ★ 19 Grade D
Profitability
8
Balance Sheet
9
Earnings Quality
51
Growth
52
Value
23
Momentum
50
Safety
0
Cash Flow
22
The InsiderStreet Scorecard rates companies across eight dimensions: Profitability (margins, ROA, ROE), Balance Sheet (leverage, liquidity, coverage), Earnings Quality (accruals, cash conversion), Growth (revenue and earnings trajectory), Value (P/E, P/B, earnings yield, Graham criteria), Momentum (revenue and earnings acceleration), Safety (Altman Z-Score risk adjustment), and Cash Flow (operating cash flow quality, FCF conversion, cash coverage). The overall score blends 35% quality, 35% value, and 30% momentum, with a penalty for distress-zone Altman scores. CTEV scores highest in Growth (52/100) and lowest in Safety (0/100). A grade of D flags significant fundamental concerns across multiple dimensions.

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score
-0.42
Distress Zone
Piotroski F-Score
4/9
✗ ✓ ✗ ✓ ✗ ✓ ✗ ✗ ✓
Beneish M-Score
0.94
Possible Manipulator
Ohlson O-Score
-5.08
Bankruptcy prob: 0.6%
Low Risk
Credit Rating
CCC
Score: 11.7/100
Trend: Stable
Earnings Quality
—
OCF/NI: -0.47x
Accruals: -8.5%
The Altman Z-Score (1968) combines five ratios — working capital, retained earnings, EBIT, market value of equity, and sales, all relative to total assets or liabilities — into a single bankruptcy predictor. CTEV scores -0.42, placing it in the Distress Zone (safe > 2.99, distress < 1.81). Historically, companies in this range face elevated bankruptcy risk. The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. CTEV scores 4/9, indicating moderate financial health — some areas of strength offset by weaknesses in others. The Beneish M-Score (1999) is an 8-variable model that detects earnings manipulation by comparing year-over-year changes in receivables, gross margins, asset quality, sales growth, depreciation, SG&A, leverage, and accruals. Scores above −1.78 statistically resemble past manipulators. CTEV's score of 0.94 exceeds the −1.78 red flag threshold — this does not confirm manipulation but indicates the earnings profile resembles past manipulators statistically. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. CTEV's implied 0.6% bankruptcy probability is well within safe territory. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. CTEV receives an estimated rating of CCC (score: 11.7/100), with a stable trend.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E
-1.33x
PEG
-0.02x
P/S
0.39x
P/B
-1.30x
P/FCF
-32.28x
P/OCF
4.35x
EV/EBITDA
9.92x
EV/Revenue
5.21x
EV/EBIT
67.92x
EV/FCF
-289.34x
Earnings Yield
-48.92%
FCF Yield
-3.10%
Shareholder Yield
0.61%
Graham Number
—
Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. CTEV currently has negative earnings — the P/E ratio is not meaningful.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden
0.878
NI / EBT
×
Interest Burden
-4.223
EBT / EBIT
×
EBIT Margin
0.077
EBIT / Rev
×
Asset Turnover
0.202
Rev / Assets
×
Equity Multiplier
-29.407
Assets / Equity
=
ROE
169.3%
The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. CTEV's ROE of 169.3% is driven by Asset Turnover (0.202), indicating efficient use of assets to generate revenue.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Two adjustments we make, and why. Growth is capped at 15%. Graham defined g as expected growth over the next seven to ten years, not last year's rate. Across US companies since 1994 the median realized 7-year EPS growth is 5–8% regardless of how fast a company grew beforehand, and of 4,457 company-quarters that grew faster than 200%, none sustained it. Uncapped, the formula assigned fair multiples in the hundreds to companies that had never held that rate — and scored worse than simply reading the P/E. Capped, it carries real information. The verdict has three states, not two. Tested over 377,249 stock-months, this ratio only separates outcomes at its extremes: below 0.25 beat the universe by 1.3 points a year, above 3.0 lagged by 2.7, and everything in between sat inside a one-point band. Rather than call two-thirds of the market "undervalued" on a threshold of 1.0, we say Neutral where the model cannot tell — which is most of the time.

Adj. Growth Rate
0.00%
Fair P/E
8.50x
Intrinsic Value
—
Price/Value
—
Margin of Safety
—
Premium
—

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 422 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price
$22.63
Median 1Y
$9.87
5th Pctile
$1.33
95th Pctile
$74.10
Ann. Volatility
116.5%
Analyst Target
$52.00
25th–75th percentile 5th–95th percentile Median path Historical Analyst target

Workforce & Productivity

Workforce efficiency metrics measuring revenue, profit, and R&D spend per employee — key indicators of operational leverage and human capital productivity.

Employees
3,000
Revenue / Employee
$321,804
Rev: $965,413,000
Profit / Employee
$-94,761
NI: $-284,282,000
SGA / Employee
$73,839
Avg labor cost proxy

Scaling Efficiency

All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability
Metric Trend Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
ROE -4.8% 3.4% 2.0% 1.6% 2.5% 1.7% 1.69%
ROA -1.4% -2.6% -4.1% -5.8% -5.8% -5.8% -5.76%
ROIC 0.2% 0.5% 0.6% 0.8% 0.8% 0.9% 0.89%
ROCE 0.0% 0.4% 1.5% 1.4% 1.5% 1.7% 1.69%
Gross Margin 73.9% 74.8% 74.8% 68.4% 26.4% 9.1% 9.09%
Operating Margin 4.2% 6.9% 4.1% 3.5% 2.7% 9.1% 9.09%
Net Margin -30.8% -25.9% -28.4% -32.7% -30.1% -23.0% -23.00%
EBITDA Margin 49.0% 53.3% 67.9% 42.5% 47.7% 52.2% 52.16%
FCF Margin -29.8% -6.8% -6.8% -1.3% -3.7% -1.8% -1.80%
OCF Margin -13.0% 6.6% 7.1% 12.2% 10.4% 13.4% 13.37%
ROIC Economic snapshot only 0.89%
Cash ROA snapshot only 2.79%
Cash ROIC snapshot only 3.08%
CROIC snapshot only -0.42%
NOPAT Margin snapshot only 3.88%
Pretax Margin snapshot only -32.42%
R&D / Revenue snapshot only 0.00%
SGA / Revenue snapshot only 21.05%
SBC / Revenue snapshot only 2.22%
Valuation
Metric Trend Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
P/E Ratio -4.71 -5.54 -4.29 -2.47 -0.95 -2.04 -1.332
P/S Ratio 1.45 1.57 1.22 0.73 0.28 0.58 0.386
P/B Ratio 22.64 -18.61 -8.59 -4.04 -1.13 -1.96 -1.304
P/FCF -4.87 -22.98 -17.98 -57.23 -7.60 -32.28 -32.285
P/OCF — 23.81 17.14 5.99 2.68 4.35 4.350
EV/EBITDA 43.64 22.04 13.38 10.35 9.39 9.92 9.917
EV/Revenue 21.37 11.28 7.62 5.51 4.97 5.21 5.214
EV/EBIT 2796.61 287.14 74.34 80.38 69.86 67.92 67.918
EV/FCF -71.74 -165.15 -112.56 -433.17 -135.38 -289.34 -289.336
Earnings Yield -21.2% -18.0% -23.3% -40.5% -1.1% -48.9% -48.92%
FCF Yield -20.5% -4.4% -5.6% -1.7% -13.2% -3.1% -3.10%
EV/OCF snapshot only 38.983
EV/Gross Profit snapshot only 11.778
Acquirers Multiple snapshot only 106.220
Shareholder Yield snapshot only 0.61%
Leverage & Solvency
Metric Trend Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Current Ratio 1.02 0.98 1.21 0.86 1.28 1.00 0.995
Quick Ratio 1.02 0.98 1.21 0.86 1.28 1.00 0.995
Debt/Equity 312.43 -116.50 -45.69 -26.64 -19.11 -15.69 -15.690
Net Debt/Equity 310.87 — — — — — —
Debt/Assets 0.91 0.92 0.93 0.95 0.95 0.97 0.970
Debt/EBITDA 40.88 19.20 11.37 9.01 8.91 8.84 8.838
Net Debt/EBITDA 40.67 18.97 11.25 8.98 8.87 8.81 8.811
Interest Coverage 0.02 0.10 0.25 0.17 0.17 0.19 0.191
Equity Multiplier 342.97 -127.09 -49.00 -28.11 -20.07 -16.17 -16.173
Cash Ratio snapshot only 0.061
Debt Service Coverage snapshot only 1.311
Cash to Debt snapshot only 0.003
FCF to Debt snapshot only -0.004
Defensive Interval snapshot only 152.2 days
Efficiency & Turnover
Metric Trend Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Asset Turnover 0.05 0.09 0.14 0.20 0.20 0.20 0.202
Inventory Turnover — — — — — — —
Receivables Turnover 2.48 3.83 5.05 6.99 8.35 7.30 7.301
Payables Turnover 1.75 2.79 4.71 4.32 8.14 11.08 11.076
DSO 147 95 72 52 44 50 50.0 days
DIO 0 0 0 0 0 0 0.0 days
DPO 208 131 78 84 45 33 33.0 days
Cash Conversion Cycle -61 -35 -5 -32 -1 17 17.0 days
Fixed Asset Turnover snapshot only 2.670
Cash Velocity snapshot only 69.204
Capital Intensity snapshot only 4.789
Growth (YoY)
Metric Trend Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Revenue — — — — 3.2% 1.1% 1.10%
Net Income — — — — -3.0% -1.1% -1.11%
EPS — — — — -2.9% -1.0% -1.05%
FCF — — — — 47.9% 44.5% 44.52%
EBITDA — — — — 3.6% 1.2% 1.16%
Op. Income — — — — 3.3% 85.5% 85.50%
OCF Growth snapshot only 3.27%
Asset Growth snapshot only -6.08%
Debt Growth snapshot only -0.60%
Shares Change snapshot only 3.11%
Growth Quality
Metric Trend Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Revenue Stability — — — — — — —
Earnings Stability — — — — — — —
Margin Stability — — — — — — —
Rev. Growth Consistency 0.00 0.00 0.00 0.00 0.50 0.50 0.500
Earn. Growth Consistency 0.00 0.00 0.00 0.00 0.00 0.00 0.000
FCF Positive Streak 0 0 0 0 0 0 0
Earnings Persistence — — — — — — —
Earnings Smoothness — — — — — — —
ROE Trend — — — — — — —
Gross Margin Trend — — — — — — —
FCF Margin Trend — — — — — — —
Sustainable Growth Rate — — — — — — —
Internal Growth Rate — — — — — — —
Cash Flow Quality
Metric Trend Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
OCF/Net Income 0.42 -0.23 -0.25 -0.41 -0.35 -0.47 -0.470
FCF/OCF 2.29 -1.04 -0.95 -0.10 -0.35 -0.13 -0.135
FCF/Net Income snapshot only 0.063
OCF/EBITDA snapshot only 0.254
CapEx/Revenue 16.8% 13.4% 13.9% 13.4% 14.0% 15.2% 15.18%
CapEx/Depreciation snapshot only 0.338
Accruals Ratio -0.01 -0.03 -0.05 -0.08 -0.08 -0.08 -0.085
Sloan Accruals snapshot only -0.090
Cash Flow Adequacy snapshot only 0.881
Dividends & Buybacks
Metric Trend Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Dividend Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Dividend/Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Payout Ratio — — — — — — —
FCF Payout Ratio — — — — — — —
Total Payout Ratio — — — — — — —
Div. Increase Streak — — — — — — —
Chowder Number — — — — — — —
Buyback Yield 0.1% 0.0% 0.0% 0.0% 0.0% 0.6% 0.61%
Net Buyback Yield 0.1% -0.0% -0.0% -0.1% -0.5% 0.4% 0.37%
Total Shareholder Return 0.1% -0.0% -0.0% -0.1% -0.5% 0.4% 0.37%
DuPont Factors
Metric Trend Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Tax Burden (NI/EBT) 0.79 0.78 0.93 0.87 0.87 0.88 0.878
Interest Burden (EBT/EBIT) -50.83 -9.30 -2.97 -4.93 -4.73 -4.22 -4.223
EBIT Margin 0.01 0.04 0.10 0.07 0.07 0.08 0.077
Asset Turnover 0.05 0.09 0.14 0.20 0.20 0.20 0.202
Equity Multiplier 342.97 -127.09 -49.00 -28.11 -43.85 -29.41 -29.407
Per Share
Metric Trend Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
EPS (Diluted TTM) $-4.38 $-8.14 $-12.36 $-17.30 $-17.16 $-16.69 $-16.69
Book Value/Share $0.91 $-2.43 $-6.18 $-10.58 $-14.45 $-17.36 $-16.97
Tangible Book/Share $-278.29 $-273.33 $-271.43 $-271.64 $-266.33 $-260.14 $-260.14
Revenue/Share $14.22 $28.74 $43.62 $58.74 $58.64 $58.63 $58.63
FCF/Share $-4.24 $-1.96 $-2.95 $-0.75 $-2.15 $-1.06 $-1.06
OCF/Share $-1.85 $1.90 $3.10 $7.14 $6.09 $7.84 $7.84
Cash/Share $1.42 $3.43 $3.07 $1.02 $1.28 $0.85 $0.85
EBITDA/Share $6.96 $14.72 $24.83 $31.27 $31.00 $30.82 $30.82
Debt/Share $284.63 $282.57 $282.30 $281.86 $276.11 $272.43 $272.43
Net Debt/Share $283.21 $279.14 $279.23 $280.83 $274.83 $271.58 $271.58
Academic Models
Metric Trend Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Altman Z-Score — — — — — — -0.423
Altman Z-Prime snapshot only -1.527
Piotroski F-Score 2 3 3 3 4 4 4
Beneish M-Score — — — — -1.66 0.94 0.944
Ohlson O-Score snapshot only -5.075
Net-Net WC snapshot only $-283.84
EVA snapshot only $-392711640.00
Credit
Metric Trend Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Credit Rating snapshot only CCC
Credit Score 9.57 11.34 15.85 11.23 15.35 11.70 11.697
Credit Grade snapshot only 17
Credit Trend snapshot only 0.361
Implied Spread (bps) snapshot only 1200.000
Industry Credit Rank snapshot only 3
Sector Credit Rank snapshot only 0

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms